Acrivon Therapeutics Inc (ACRV)
9.59
+1.13
(+13.36%)
USD |
NASDAQ |
May 03, 16:00
9.50
-0.09
(-0.94%)
After-Hours: 20:00
Acrivon Therapeutics Total Assets (Quarterly): 138.26M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 138.26M |
| September 30, 2023 | 151.09M |
| June 30, 2023 | 160.05M |
| March 31, 2023 | 170.20M |
| Date | Value |
|---|---|
| December 31, 2022 | 181.23M |
| September 30, 2022 | 87.71M |
| June 30, 2022 | 95.00M |
| December 31, 2021 | 106.59M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
87.71M
Minimum
Sep 2022
181.23M
Maximum
Dec 2022
136.27M
Average
144.68M
Median
Total Assets (Quarterly) Benchmarks
| MyMD Pharmaceuticals Inc | 17.86M |
| Vincerx Pharma Inc | 18.22M |
| GlycoMimetics Inc | 45.32M |
| Immunic Inc | 54.30M |
| Skye Bioscience Inc | 11.94M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 17.07M |
| Shareholders Equity (Quarterly) | 121.20M |